Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Enhanced Selective Inhibition of KRAS Mutant Hematopoietic Progenitor Cell Expansion By MEK and Bcl-2 Inhibition

Huan-Ting Lin, PhD, Kenji Kubara, Kazuto Yamazaki, PhD, Masatoshi Takagi, MD PhD, Takuya Naruto, MD PhD, Tomohiro Morio, MD PhD, Takashi Okumura, PhD, Makoto Otsu, MD PhD

Blood (2018) 132 (Supplement 1): 1278.

https://doi.org/10.1182/blood-2018-99-117889

Published: 2018

Journal Articles

Indolent Phenotype of RAS-Associated Autoimmune Leukoproliferative Disorder (RALD) Is Characterized By Single Somatic Mutations in RAS Genes with Absence of Cooperating Mutations

Vollter Anastas, B.S., Weixin Wang, PhD, Susan Price, Zhen Zhao, PhD, V. Koneti Rao, MD, Katherine R. Calvo, MD PhD

Blood (2016) 128 (22): 4268.

https://doi.org/10.1182/blood.V128.22.4268.4268

Published: 2016

Journal Articles

Whole-Exome Analysis of Autoimmune Lymphoproliferative Syndrome-like Diseases

Masatoshi Takagi, MD PhD, Kohsuke Imai, MD PhD, Jinhua Piao, DDS, PhD, Motoy Yamashita, MD, Akihiro Hoshino, MD, Tsubasa Okano, MD, Hirokazu Kanegane, MD PhD, Hideki Muramatsu, MD PhD, Yusuke Okuno, MD PhD, Yuichi Shiraishi, MD PhD, Kenichi Chiba, BA, Hiroko Tanaka, BA, Satoru Miyano, MD PhD, Kenichi Yoshida, MD PhD, Hiroo Ueno, MD, Seishi Ogawa, MD PhD, Yasuhide Hayashi, MD PhD, Seiji Kojima, MD PhD, Tomohiro Morio, MD PhD

Blood (2015) 126 (23): 1022.

https://doi.org/10.1182/blood.V126.23.1022.1022

Published: 2015

Journal Articles

JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities

Katherine R. Calvo, Susan Price, Raul C. Braylan, Joao Bosco Oliveira, Michael Lenardo, Thomas A. Fleisher, V. Koneti Rao

Blood (2015) 125 (18): 2753–2758.

https://doi.org/10.1182/blood-2014-11-567917

Published: 2015

Includes: Supplemental data

Journal Articles

Clinical Spectrum of RAS-Associated Autoimmune Leukoproliferative Disorder (RALD): A Distinct Clinical Entity Mimicking Juvenile Myelomonocytioc Leukemia (JMML) or Chronic Myelomonocytic Leukemia (CMML)

V. Koneti Rao, Joao Bosco Oliveira, MD, PhD, Julie Niemela, PhD, Joie Davis, NP, Susan Price, Hyesun Kuehn, Katherine R Calvo, MD, PhD, Stefania Pittaluga, Eric J. Werner, MD, Joohee Lee, MD, Mustafa Barbour, MD, Marc Natter, MD, Mignon L. Loh, MD, Thomas A Fleisher

Blood (2012) 120 (21): 1033.

https://doi.org/10.1182/blood.V120.21.1033.1033

Published: 2012

Journal Articles

Clinico-Pathological Characteristics of RAS Associated Autoimmune Lymphoproliferative Syndrome Like Disease (RALD), and RAS Mutated Juvenile Myelomonocytic Leukemia (JMML)

Masatoshi Takagi, MD, PhD, Tomohiro Morio, MD, PhD, Kenichi Koike, MD, PhD, Shuki Mizutani, MD, PhD

Blood (2011) 118 (21): 5169.

https://doi.org/10.1182/blood.V118.21.5169.5169

Published: 2011

Journal Articles

Autoimmune lymphoproliferative syndrome–like disease with somatic KRAS mutation

Masatoshi Takagi, Kunihiro Shinoda, Jinhua Piao, Noriko Mitsuiki, Mari Takagi, Kazuyuki Matsuda, Hideki Muramatsu, Sayoko Doisaki, Masayuki Nagasawa, Tomohiro Morio, Yoshihito Kasahara, Kenichi Koike, Seiji Kojima, Akira Takao, Shuki Mizutani

Blood (2011) 117 (10): 2887–2890.

https://doi.org/10.1182/blood-2010-08-301515

Published: 2011

Includes: Supplemental data

NARROW

Enhanced Selective Inhibition of KRAS Mutant Hematopoietic Progenitor Cell Expansion By MEK and Bcl-2 Inhibition

Indolent Phenotype of RAS-Associated Autoimmune Leukoproliferative Disorder (RALD) Is Characterized By Single Somatic Mutations in RAS Genes with Absence of Cooperating Mutations

Whole-Exome Analysis of Autoimmune Lymphoproliferative Syndrome-like Diseases

JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities

Clinical Spectrum of RAS-Associated Autoimmune Leukoproliferative Disorder (RALD): A Distinct Clinical Entity Mimicking Juvenile Myelomonocytioc Leukemia (JMML) or Chronic Myelomonocytic Leukemia (CMML)

Clinico-Pathological Characteristics of RAS Associated Autoimmune Lymphoproliferative Syndrome Like Disease (RALD), and RAS Mutated Juvenile Myelomonocytic Leukemia (JMML)

Autoimmune lymphoproliferative syndrome–like disease with somatic KRAS mutation

Email alerts

ASH Publications

American Society of Hematology

Enhanced Selective Inhibition of KRAS Mutant Hematopoietic Progenitor Cell Expansion By MEK and Bcl-2 Inhibition

Indolent Phenotype of RAS-Associated Autoimmune Leukoproliferative Disorder (RALD) Is Characterized By Single Somatic Mutations in RAS Genes with Absence of Cooperating Mutations

Whole-Exome Analysis of Autoimmune Lymphoproliferative Syndrome-like Diseases

JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities

Clinical Spectrum of RAS-Associated Autoimmune Leukoproliferative Disorder (RALD): A Distinct Clinical Entity Mimicking Juvenile Myelomonocytioc Leukemia (JMML) or Chronic Myelomonocytic Leukemia (CMML)

Clinico-Pathological Characteristics of RAS Associated Autoimmune Lymphoproliferative Syndrome Like Disease (RALD), and RAS Mutated Juvenile Myelomonocytic Leukemia (JMML)

Autoimmune lymphoproliferative syndrome–like disease with somatic KRAS mutation

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only